Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Choline Alphoscerate on Cognitive Function in Alzheimer's Dementia: A Multi-center, Randomized, Open-label, Pilot Study

NCT03441516 is registered in ClinicalTrials.gov with Yuhan Corporation as lead sponsor.

NCT NCT03441516
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03441516 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Choline Alphoscerate on Cognitive Function in Alzheimer's Dementia: A Multi-center, Randomized, Open-label, Pilot Study
Lead sponsor
Yuhan Corporation
Phase
Phase 4
Overall status
Unknown status
Start date
April 19, 2018
Completion date
December 31, 2021
Enrollment
79 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease